These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comparison of Escherichia coli susceptibility to cephalothin, cefazolin, ceforanide, and cefamandole. Greenberg RN, Bollinger M. Clin Ther; 1985; 7(2):151-3. PubMed ID: 3886140 [Abstract] [Full Text] [Related]
3. Antimicrobial activities and susceptibility testing considerations of ampicillin, cephalothin, cefaclor, and cefuroxime against invasive isolates of Haemophilus influenzae. Shelton MM, Welch DF. Chemotherapy; 1989; 35(2):88-94. PubMed ID: 2788068 [Abstract] [Full Text] [Related]
4. Summary of laboratory studies on the antibacterial activity of cefaclor. Preston DA. Postgrad Med J; 1979; 55 Suppl 4():22-9. PubMed ID: 398479 [Abstract] [Full Text] [Related]
5. Variable in vitro activity of cefaclor, cephalothin and cefadroxil against Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis. Larsson P, Lincoln K, Lind L, Sandberg T. Scand J Infect Dis; 1988; 20(4):421-4. PubMed ID: 3057617 [Abstract] [Full Text] [Related]
6. [Antibacterial activity of cefotaxim in comparison with seven cephalosporins]. Braveny I, Dickert H, Machka K. Infection; 1979; 7(5):231-6. PubMed ID: 389804 [Abstract] [Full Text] [Related]
8. Prevalence of antimicrobial resistance among clinical isolates of Haemophilus influenzae: a collaborative study. Doern GV, Jorgensen JH, Thornsberry C, Preston DA. Diagn Microbiol Infect Dis; 1986 Feb; 4(2):95-107. PubMed ID: 3485505 [Abstract] [Full Text] [Related]
9. In-vitro activity of cefaclor, cephalexin and ampicillin against 2458 clinical isolates of Haemophilus influenzae. Powell M, Williams JD. J Antimicrob Chemother; 1988 Jan; 21(1):27-31. PubMed ID: 3258594 [Abstract] [Full Text] [Related]
10. Comparison of cefadroxil and cephalothin disk susceptibility test results. Barry AL, Jones RN. J Clin Microbiol; 1989 Jul; 27(7):1460-3. PubMed ID: 2504768 [Abstract] [Full Text] [Related]
11. Summary of laboratory studies on the antibacterial activity of cefaclor. Preston DA. Infection; 1979 Jul; 7 Suppl 6():557-61. PubMed ID: 45088 [Abstract] [Full Text] [Related]
13. Synergistic enhancement of in vitro antimicrobial activity of imipenem and cefazolin, cephalothin, cefotiam, cefamandole or cefoperazone in combination against methicillin-sensitive and -resistant Staphylococcus aureus. Uete T, Matsuo K. Jpn J Antibiot; 1995 Mar; 48(3):402-8. PubMed ID: 7752453 [Abstract] [Full Text] [Related]
14. In-vitro activities of cefamandole and cephalothin against 1,881 clinical isolates. A multi-center study. Barry AL, Schoenknect FD, Shadomy S, Sherris JC, Thornsberry C, Washington JA, Kammer RB. Am J Clin Pathol; 1979 Nov; 72(5):858-60. PubMed ID: 506998 [Abstract] [Full Text] [Related]
16. The in vitro spectrum of the cephalosporins. Washington JA. Mayo Clin Proc; 1976 Apr; 51(4):237-50. PubMed ID: 1263595 [Abstract] [Full Text] [Related]
17. National collaborative study of the prevalence of antimicrobial resistance among clinical isolates of Haemophilus influenzae. Doern GV, Jorgensen JH, Thornsberry C, Preston DA, Tubert T, Redding JS, Maher LA. Antimicrob Agents Chemother; 1988 Feb; 32(2):180-5. PubMed ID: 3259121 [Abstract] [Full Text] [Related]